Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

Nova Scotia's colorectal cancer screening program sends kits to all Nova Scotians aged 50 to 74 every two years. It is aimed at early detection and prevention. The strategy has inspired copies ...

The kit, a fecal immunochemical test (FIT), uses antibodies to detect blood in stool. This blood is an early warning sign of colon cancer, and those who test positive are urged to undergo a ...

One of Nova Scotia's cancer screening strategies may be getting revamped thanks to students at NSCAD University in Halifax. Nova Scotia's colorectal cancer screening program sends kits to all Nova ...

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...